Atopic Dermatitis Clinical Trials in North Miami Beach, Florida

4 studies are recruiting for atopic dermatitis in North Miami Beach, Florida right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis

    This is a phase 2b, multicenter, randomized, double-blind, placebo-controlled study.

    Stage
    Phase 2
    Ages
    18 to 65
    Site
    Ziaderm Research LLC, North Miami Beach, Florida
    Locations
    85 in total
    Run by
    Apollo Therapeutics Ltd
  2. This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment

    The objectives of this prospective non-interventional study are to characterize the existing unmet needs across the spectrum of atopic dermatitis (AD), enhance the understanding of the patient journey, and evaluate the safety and clinical outcomes of systemic AD treatments in a real-world setting. …

    Stage
    Not phased
    Ages
    12 and older
    Site
    Ziaderm Research, LLC- Site Number : 8400021, North Miami Beach, Florida
    Locations
    79 in total
    Run by
    Sanofi
  3. A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis

    The purpose of this study is to learn about the safety and effects of 2 study medicines (PF-07275315 and PF-07264660) for the treatment of atopic dermatitis (AD). AD is a long- lasting itchy red rash, caused by a skin reaction. This study is seeking participants who: * are 18 years of age or more. …

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Ziaderm Research LLC, North Miami Beach, Florida
    Locations
    98 in total
    Run by
    Pfizer
  4. Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults

    The main aim of the study is to assess real-world effectiveness of nemolizumab in Atopic Dermatitis (AD) as measured by physician assessment and patient reported outcome (PRO) in clinical practice at Month 6.

    Stage
    Not phased
    Ages
    12 and older
    Site
    Galderma Investigational Site 7070, North Miami Beach, Florida
    Locations
    108 in total
    Run by
    Galderma R&D

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.